AstraZeneca has announced the suspension of a 200 million pound investment in the research center in Cambridge, affecting 1,000 jobs.
Raluca Ioana Draghici
Economy
www.shutterstock.com
Always see our news on Google
AstraZeneca has decided to halt its £200 million investment plan at its research center in Cambridge, a project that would have created approximately 1,000 jobs. This is the company's second major withdrawal from the UK in 2024, after it abandoned a £450 million investment in vaccine manufacturing in January. The decisions of pharmaceutical companies, including Merck & Co., are putting pressure on the British government in the context of maintaining attractiveness for investments in the pharmaceutical sector.
Sources
AstraZeneca suspendă o investiţie de 270 de milioane de dolari în Marea Britanie
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
AstraZeneca pauses £200m Cambridge investment
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
Latest News
09:18
POLITICO / The "imaginary cows" affair. How Greek farmers "milked" EU funds with the help of some imaginary cows
09:10
EXCLUSIVE | August 21, 2026. Trends in online searches / last 24 hours
09:00
Traian Băsescu criticizes the government options that political leaders are discussing: "They mock the Constitution / They no longer care since they annulled the elections with the support of President Iohannis"
08:38
The nuclear power plant at Kozloduy, Bulgaria, is reducing capacity due to the low water level in the Danube.
08:15
Several Ukrainian soldiers may have deserted during training in Germany
See more news
NEWS ON THE SAME TOPICS
International
AstraZeneca, negotiations with Bristol Myers Squibb for a possible merger that could create a 400 billion dollar group
International
AstraZeneca announced the failure of a drug for a rare heart condition, causing a 9% drop in the company's shares.
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
